Monitor the stock's bid price closely for any sustained recovery above $1.00. The Form 20-F deadline of November 11, 2026 is the nearer-term catalyst — failure to file could trigger additional Nasdaq actions. The activist CEO's stake suggests insider alignment, but no operational turnaround plan has been disclosed.
Price Chart
Executive Summary
Medirom Healthcare Technologies Inc. disclosed receipt of a Nasdaq deficiency notice for failing to maintain the minimum $1.00 bid price for 31 consecutive business days, with a 180-day cure period until April 5, 2027. The company also remains delinquent on its Form 20-F filing, with an extended deadline of November 11, 2026. The activist stake (SC 13D/A) filed 46 days ago by CEO Kouji Eguchi adds context but does not alter the bearish delisting risk.
Key Facts
- Nasdaq notified Medirom on October 6, 2026 of non-compliance with the $1.00 minimum bid price rule (Rule 5550(a)(2)) based on 31 consecutive business days of closing bid prices below $1.00 from August 24 to October 5, 2026.
- The company has 180 calendar days, until April 5, 2027, to regain compliance by achieving a closing bid price of at least $1.00 for 10 consecutive business days.
- Medirom also remains delinquent on its Form 20-F for FY2025, with an extended compliance deadline of November 11, 2026.
- CEO Kouji Eguchi filed a Schedule 13D/A on August 28, 2026, indicating activist-level stake, though no specific demands or changes are detailed in this filing.
Financial Impact
Delisting risk is material; failure to regain compliance could lead to Nasdaq delisting, severely impacting liquidity and access to capital markets.
Risk Factors
- Failure to regain bid price compliance by April 5, 2027 could lead to delisting from Nasdaq.
- Continued delinquency on Form 20-F filing (deadline November 11, 2026) adds regulatory overhang and potential further Nasdaq non-compliance.
- No financial or operational improvement plan has been announced to address the underlying business performance driving the stock price decline.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-420488 |
| Document: mrm-ex99_1.htm | 0001193125-26-420488 |
| Document: 0001193125-26-420488-index-headers.html | 0001193125-26-420488 |
| Document: 0001193125-26-420488-index.html | 0001193125-26-420488 |
| Document: 0001193125-26-420488.txt | 0001193125-26-420488 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $0.3359 | awaiting T+20 | — | $0.3651 (−8.69%) |
Aug 7, 2026 11w ago | 6-K | $0.9600 $0.9200 | ▲ +4.17% | ▲ +3.77% | $0.3651 (+61.97%) |
Jun 25, 2026 17w ago | 6-K | $0.9970 $1.00 | ▲ +0.30% | ▼ −0.96% | $0.3651 (−63.38%) |
May 29, 2026 21w ago | 6-K | $1.11 $1.03 | ▲ +7.21% | ▲ +5.91% | $0.3651 (+67.11%) |
May 28, 2026 21w ago | Press Release | $1.14 $1.00 | ▼ −12.28% | ▼ −10.49% | $0.3651 (−67.97%) |
May 28, 2026 21w ago | 6-K | $1.14 $1.00 | ▲ +12.28% | ▲ +10.49% | $0.3651 (+67.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers